Recently M/s Novo Nordisk, Denmark organized “DUAL VIII Investigator meeting” from 24th – 26th November 2015 at Amsterdam, Netherlands. Dr. Noorul Ameen represented Orange City Hospital & Research Institute, Nagpur at this international conclave. Orange City Hospital was the only hospital from central India selected for DUAL VIII clinical trial study.
Orange City Hospital & Research Institute continues to keep itself abreast with recent updates in National and International healthcare sector. All major healthcare organizations recognize the presence of OCHRI in international clinical research platforms. A Central government approved ethical committee also functions at OCHRI.
On this occasion Dr. Noorul Ameen thanked OCHRI management led by Shri. Udaybhaskar Nair for the deputation and owed this visit to Dr.Nikhil Balankhe, Critical Care Physician & Chief Research Investigator, OCHRI, who nominated him in this conclave.
Dr.Noorul Ameen, SMO Incharge- Clinical Research, OCHRI stated that the main objective of the DUAL VIII meeting was to ensure that globally all sites have uniform information regarding the study protocol, rationale for the trial, the key operational aspects running the trial, safety of the subjects and reporting so that all over the world same protocol criteria should be followed and implemented. The meeting was attended by representatives of study sites from all over the world. Dr.Noorul Ameen has since then resumed his duties back at OCHRI after successfully partaking in this international conclave.